Crucial Conversations in Pharmacy Practice: Improving Patient Outcomes in Shingles Management
Provided by American Academy of CME, Inc.
Supported by an educational grant from GlaxoSmithKline.
September 15, 2023
September 15, 2024
Shingles management—or more specifically, the prevention of shingles (caused by varicella zoster virus; VZV)—is crucial to help preserve quality of life, particularly for older adults. Updated immunization recommendations for recombinant zoster vaccine (RZV) now include updated guidance for adults with compromised immune systems in addition to older adults. Pharmacists play a key role in the interprofessional team with appropriate identification, recommendation, and administration of age-appropriate vaccines to help prevent shingles and complications.
The web-based monograph will include text, faculty audio clips and cases representing the burden of shingles on older adults and the role of the pharmacist in making a clinical impact. This impact, ranging from clinical management to addressing racial and ethnic inequities will be addressed.
Clark Kebodeaux, Pharm.D., BCACP
Clinical Associate Professor
Pharmacy Practice and Science
University of Kentucky
College of Pharmacy
This activity is designed for pharmacists actively engaged in the care of patients that are considering herpes zoster vaccinations. Other members of the care team may also participate.
After participating in this educational activity, learners should be better able to:
- Assess the epidemiology, costs and patient impact associated with herpes zoster
- Evaluate the changes in immune system function in older people and those with compromised immune systems
- Describe the current immunization recommendations for herpes zoster in older adults and individuals with compromised immune systems and apply this knowledge to patient care
- Recognize the pharmacist's role in improving herpes zoster vaccination rates in older adults and people with compromised immune systems
In support of improving patient care, American Academy of CME, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity provides 1.50 ACPE contact hours (0.15 CEUs) of continuing education credit. Universal Activity Number JA4008191-0000-23-029-H06-P, Application
Fee Information: There is no fee to complete this activity
Estimated time to complete: 1.50 hours
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.
Clark Kebodeaux, Pharm.D., BCACP
Dr. Kebodeaux has no relevant financial relationships with any ineligible companies.
John JD Juchniewicz, MCIS, CHCP, FACEHP, Edward Moylan, RPh, Wendy Gloffke, PhD and Paul Miniter, MS - No relevant financial relationships with any ineligible companies.
Michelle Kohute, PharmD
Dr. Kohute has no relevant financial relationships with any ineligible companies.
Off Label Disclosure
This activity mentions treatments that are not currently approved in the US.
The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically and draw conclusions only after careful consideration of all available scientific information.
Method of Participation
There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CPE credit for your participation, please complete the post-test (achieving a passing grade of 70% or greater), and program evaluation. Your certificate can be printed immediately. For pharmacists, a statement of credit will be issued through CPE Monitor in 6-8 weeks. Only pharmacist learners who provided valid NABP e-Profile ID numbers and month and day of birth (MMDD) will be submitted to CPE Monitor for official record of credit.
Please ensure the computer you plan to use meets the following minimum requirements:
- Operating System: Windows 98 or higher & Macintosh 2.2 or higher
- Internet Browser (Mac &/ Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
- Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
- Monitor Screen Resolution: 320 x 480 or higher
- Media Viewing Requirements: Adobe Reader, Microsoft Powerpoint, Flash Player & HTML5
For any questions, please contact: CEServices@academycme.org
© 2023. This CPE-certified activity is held as copyrighted © by American Academy of CME, Inc. Through this notice, the Academy grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).